[1] | Dubey JP. The history of Toxoplasma gondii: the first 100 years[J]. J Eukaryot Microbiol, 2008, 55(6): 467-475. | [2] | Coppin A,, Dzierszinski F,, Legrand S, et al. Developmentally regulated biosynthesis of carbohydrate and storage polysaccharide during differentiation and tissue cyst formation in Toxoplasma gondii[J]. Biochimie, 2003, 85(3/4): 353-361. | [3] | Dubey JP,, Lindsay DS,, Speer CA. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts[J]. Clin Microbiol Rev, 1998, 11(2): 267-299. | [4] | Alday PH,, Doggett JS. Drugs in development for toxoplasmosis: advances, challenges, and current status[J]. Drug Des Dev Ther, 2017, 11: 273-293. | [5] | Parmley SF,, Weiss LM,, Yang S. Cloning of a bradyzoite-specific gene of Toxoplasma gondii encoding a cytoplasmic antigen[J]. Mol Biochem Parasitol, 1995, 73(1/2): 253-257. | [6] | Bohne W,, Gross U,, Ferguson DJ, et al. Cloning and characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants[J]. Mol Microbiol, 1995, 16(6): 1221-1230. | [7] | Ma YF,, Zhang YW,, Kim K, et al. Identification and characterisation of a regulatory region in the Toxoplasma gondii hsp70 genomic locus[J]. Int J Parasitol, 2004, 34(3): 333-346. | [8] | Li CJ,, Zhou TY,, Yu ZQ, et al. Effects of Toxoplasma gondii heat shock protein 21 on the function of mouse macrophage in vitro[J]. J Nanjing Agric Univ, 2021, 44(1): 136-143. (in Chinese) | [8] | ( 李纯静,, 周天缘,, 于正青, 等. 刚地弓形虫热休克蛋白21体外条件下对小鼠巨噬细胞功能的影响[J]. 南京农业大学学报, 2021, 44(1): 136-143.) | [9] | Mun HS,, Aosai F,, Yano A. Role of Toxoplasma gondii HSP70 and Toxoplasma gondii HSP30/BAG1 in antibody formation and prophylactic immunity in mice experimentally infected with Toxoplasma gondii[J]. Microbiol Immunol, 1999, 43(5): 471-479. | [10] | di Cristina M,, del Porto P,, Buffolano W, et al. The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection[J]. Microbes Infect, 2004, 6(2): 164-171. | [11] | Zhang YW,, Kim K,, Ma YF, et al. Disruption of the Toxoplasma gondii bradyzoite-specific gene BAG1 decreases in vivo cyst formation[J]. Mol Microbiol, 1999, 31(2): 691-701. | [12] | Yin Q. Construction of a Δbag1Δku80 strain and evaluation of its safety, immunogenicity and efficacy as a vaccine candidate against cat toxoplasmosis[D]. Beijing: China Agricultural University, 2015: 66-71. (in Chinese) | [12] | ( 尹青. 弓形虫Δbag1Δku80株的构建及其作为猫弓形虫病疫苗候选株的免疫原性、安全性和效力的评价[D]. 北京: 中国农业大学, 2015: 66-71.) | [13] | Ascoli CA,, Aggeler B. Overlooked benefits of using polyclonal antibodies[J]. Biotechniques, 2018, 65(3): 127-136. | [14] | Posner J,, Barrington P,, Brier T, et al. Monoclonal antibodies: past, present and future[J]. Handb Exp Pharmacol, 2019, 260: 81-141. | [15] | Wang P,, Lu GL,, Fan YJ, et al. Seroepidemiological survey of Toxoplasma gondii in dogs in Urumqi[J]. Chin J Parasitol Parasit Dis, 2014, 32(5): 404-405. (in Chinese) | [15] | ( 汪萍,, 陆桂丽,, 范玉娟, 等. 乌鲁木齐市犬弓形虫血清流行病学调查与分析[J]. 中国寄生虫学与寄生虫病杂志, 2014, 32(5): 404-405.) | [16] | Deng Y,, Wu T,, Zhai SQ, et al. Recent progress on anti-Toxoplasma drugs discovery: design, synthesis and screening[J]. Eur J Med Chem, 2019, 183: 111711. | [17] | Yao N,, Gong JZ,, Fan YM, et al. Research progress on drugs for the treatment of toxoplasmosis[J]. China Animal Husb & Vet Med, 2020, 47(4): 1250-1257. (in Chinese) | [17] | ( 姚娜,, 龚静芝,, 范益敏, 等. 弓形虫病治疗药物的研究进展[J]. 中国畜牧兽医, 2020, 47(4): 1250-1257.) | [18] | Shao RG. Monoclonal antibody-based cancer immunotherapy[J]. Acta Pharm Sin, 2020, 55(6): 1110-1118. (in Chinese) | [18] | ( 邵荣光. 基于单克隆抗体的肿瘤免疫治疗[J]. 药学学报, 2020, 55(6): 1110-1118.) | [19] | Ding JQ,, Wu K,, Tan F, et al. Establishment of an in vitro tachyzoite-bradyzoite interconversion system for Toxoplasma gondii[J]. J South Med Univ, 2010, 30(4): 668-671. (in Chinese) | [19] | ( 丁洁琼,, 吴焜,, 谭峰, 等. 弓形虫速殖子与缓殖子体外转化体系的建立[J]. 南方医科大学学报, 2010, 30(4): 668-671.) | [20] | Tobin C,, Pollard A,, Knoll L. Toxoplasma gondii cyst wall formation in activated bone marrow-derived macrophages and bradyzoite conditions[J]. J Vis Exp, 2010(42): 2091. |
|